Bibliotecas PUC-SP - Busca Integrada

Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways

Por Masmudur M. Rahman, Grant McFadden
Publicado no Vaccines (2020-05-01)

Oncolytic Virotherapy with Myxoma Virus

Por Masmudur M. Rahman, Grant McFadden
Publicado no Journal of Clinical Medicine (2020-01-01)

Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy

Por Masmudur M. Rahman, Grant McFadden
Publicado no Cancers (2021-10-01)

Modulation of tumor necrosis factor by microbial pathogens.

Por Masmudur M Rahman, Grant McFadden
Publicado no PLoS Pathogens (2006-02-01)

Myxoma Virus dsRNA Binding Protein M029  Inhibits the Type I IFN‐Induced Antiviral State in a  Highly Species‐Specific Fashion

Por Masmudur M. Rahman, Grant McFadden
Publicado no Viruses (2017-02-01)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy

Por Junior A. Enow, Hummad I. Sheikh, Masmudur M. Rahman
Publicado no Viruses (2023-11-01)

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

Por Nancy Y. Villa, Masmudur M. Rahman, Grant McFadden, Christopher R. Cogle
Publicado no Viruses (2016-03-01)

Oncolytic Virotherapy for Hematological Malignancies

Por Swarna Bais, Eric Bartee, Masmudur M. Rahman, Grant McFadden, Christopher R. Cogle
Publicado no Advances in Virology (2012-01-01)

Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication.

Por Masmudur M Rahman, Jia Liu, Winnie M Chan, Stefan Rothenburg, Grant McFadden
Publicado no PLoS Pathogens (2013-01-01)

Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013.

Por Masmudur M Rahman, Mohamed R Mohamed, Manbok Kim, Sherin Smallwood, Grant McFadden
Publicado no PLoS Pathogens (2009-10-01)

The Role of Myxoma Virus Immune Modulators and Host Range Factors in Pathogenesis and Species Leaping

Por Junior A. Enow, Ana M. Lopes, Joana Abrantes, Pedro J. Esteves, Masmudur M. Rahman
Publicado no Viruses (2025-08-01)

Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma

Por Michael P. Phelps, Heechang Yang, Shivani Patel, Masmudur M. Rahman, Grant McFadden, Eleanor Chen
Publicado no Molecular Therapy: Oncolytics (2018-12-01)

Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma

Por Joanna Jazowiecka-Rakus, Aleksander Sochanik, Agata Hadryś, Wojciech Fidyk, Ewa Chmielik, Masmudur M. Rahman, Grant McFadden
Publicado no Cancers (2022-04-01)

The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase

Por Yanghee Woo, Susanne G Warner, Rula Geha, Marianne M Stanford, Penelope Decarolis, Masmudur M Rahman, Samuel Singer, Grant McFadden, Yuman Fong
Publicado no Clinical Medicine Insights: Oncology (2021-02-01)

Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma

Por Joanna Jazowiecka-Rakus, Agata Hadrys, Masmudur M. Rahman, Grant McFadden, Wojciech Fidyk, Ewa Chmielik, Marlena Pazdzior, Maciej Grajek, Violetta Kozik, Aleksander Sochanik
Publicado no Cancers (2021-03-01)

Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.

Por Henry Ogbomo, Franz J Zemp, Xueqing Lun, Jiqing Zhang, Danuta Stack, Masmudur M Rahman, Grant McFadden, Christopher H Mody, Peter A Forsyth
Publicado no PLoS ONE (2013-01-01)

Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma

Por Joanna Jazowiecka-Rakus, Aleksander Sochanik, Aleksandra Rusin, Agata Hadryś, Wojciech Fidyk, Nancy Villa, Masmudur M. Rahman, Ewa Chmielik, Lina S. Franco, Grant McFadden
Publicado no Molecular Therapy: Oncolytics (2020-09-01)

Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication

Por Masmudur M. Rahman, Bereket Estifanos, Honor L. Glenn, Ami D. Gutierrez-Jensen, Karen Kibler, Yize Li, Bertram Jacobs, Grant McFadden, Brenda G. Hogue
Publicado no Viruses (2025-02-01)

Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma

Por John D. Christie, Nicole Appel, Liqiang Zhang, Kenneth Lowe, Jacquelyn Kilbourne, Juliane Daggett-Vondras, Natalie Elliott, Alexandra R. Lucas, Joseph N. Blattman, Masmudur M. Rahman, Grant McFadden
Publicado no Cancers (2022-01-01)

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

Por Cameron L. Lilly, Nancy Y. Villa, Ana Lemos de Matos, Haider M. Ali, Jess-Karan S. Dhillon, Tom Hofland, Masmudur M. Rahman, Winnie Chan, Bjarne Bogen, Christopher Cogle, Grant McFadden
Publicado no Molecular Therapy: Oncolytics (2017-03-01)